艾裏德克斯 IRIX 深 滬
等待開盤 06-25 09:30:00 美东时间
1.19
+0.010
+0.85%
華盛通- 最 高1.20
- 今 開1.18
- 成交量 2.27万股
- 最 低 1.18
- 昨 收 1.18
- 總市值 2071.38万
- 52周最高 1.6481
- 市盈率 靜 --
- 換手率 0.13%
- 52周最低 0.8688
- 委 比 -30.01%
- 總股本 1740.65万
- 歷史最高 16.64
- 量 比 0.38
- 振 幅 1.69%
- 歷史最低 0.782
- 每 手 1
- 風險率 0.18%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Iridex Adjourns 2026 Annual Meeting, Plans July Reconvening
Iridex ( ($IRIX) ) has provided an announcement. On June 12, 2026, Iridex Corpo...
06-19 04:33
Iridex to Present at the Planet MicroCap Las Vegas 2026 Conference
<p>Iridex Corporation, a global leader in laser-based medical systems for treating glaucoma and retinal diseases, announced its participation in the Planet MicroCap Las Vegas 2026 Conference. Management will present on June 17, 2026, at 4:00 pm PT. The presentation will be available live and archived on the company’s website. Iridex specializes in innovative laser technologies, including its MicroPulse® system, used for treating glaucoma and diab...
06-09 20:05
IRIDEX CFO Romeo R. Dizon reports purchase of 2,521 shares for $2,899.15
IRIDEX CFO Romeo R. Dizon reports purchase of 2,521 shares for $2,899.15 IRIDEX Corp CFO Romeo R. Dizon bought 2,521 common shares at USD 1.15 each. Directly held common stock rose to 130,925 shares following the purchase. Disclaimer: This news brief was created by Public Technologies (PUBT) using g
06-08 21:54
电话会总结 ｜ Iridex(IRIX)2026财年Q1业绩电话会核心要点
<span style="color:#999999;">编者按：聚焦公司高管观点与展望，深挖业绩背后的信息，助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据IRIDEX业绩会实录，以下是财务业绩回顾摘要： ## 1. 财务业绩 **营收表现：** 2026年第一季度总营收1,180万美元，与去年同期基本持平（去年同期1,190万美元），符合公司此前指引预期。 **盈利能力：** 毛利润470万美元，毛利率40%；营业费用510万美元；营业亏损30万美元；净亏损50万美元（每股亏损0.03美元）。 **现金状况：** 截至2026年4月4日，现金及现金等价物460万美元，本季度现金减少140万美元。 ## 2. 财务指标变化 **营收变化：** - 同比：总营收基本持平（-0.8%） - 产品线表现
05-20 12:13
Iridex Q1 2026 Earnings Call: Complete Transcript
Iridex (NASDAQ:IRIX) released first-quarter financial results and hosted an ear...
05-20 05:49
Iridex Affirms FY2026 Sales Guidance of $51.000M-$53.000M vs $53.227M Est
Iridex (NASDAQ:IRIX) affirms FY2026 sales outlook from $51.000 million-$53.000 million to $51.000 million-$53.000 million vs $53.227 million estimate.
05-20 04:18
Iridex Q1 EPS $(0.03) Beats $(0.07) Estimate, Sales $11.799M Miss $11.910M Estimate
Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.07) by 57.14 percent. This is a 70 percent increase over losses of $(0.10) per share from the same
05-20 04:17
Iridex Reports First Quarter 2026 Financial Results
Iridex Corporation reported first-quarter 2026 revenue of $11.8 million, a 1% decrease from the prior year, driven by lower retina product sales. The Cyclo G6 product family revenue grew 14% to $3.6 million, while retina product revenue declined 12% to $5.8 million. Operating expenses decreased 4% to $5.1 million, and the net loss narrowed to $0.5 million, or $0.03 per share. The company reaffirmed its full-year 2026 revenue guidance of $51 milli...
05-19 20:05
Earnings Scheduled For May 19, 2026
Companies Reporting Before The Bell • Radcom (NASDAQ:RDCM) is expected to repor...
05-19 19:11
美股夜盘 | 优品车涨72.29%，Megan Holdings Limited Class A涨27.23%
优品车涨72.29%；Megan Holdings Limited Class A涨27.23%；Skillsoft Corp Class A涨25.40%
04-08 15:01
